Skip to main content
logo
Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1360
-0.0065 (-4.56%)
At close: Jul 24, 2026, 4:00 PM EDT
0.1339
-0.0021 (-1.54%)
After-hours: Jul 24, 2026, 7:49 PM EDT

Gossamer Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
55.5448.47114.7---
Revenue Growth (YoY)
-55.42%-57.74%----
Gross Profit
55.5448.47114.7---
Selling, General & Admin
47.7237.6336.1338.4647.6145.78
Research & Development
179.13181.57138.49145.3170.98170.34
Total Operating Expenses
226.85219.2174.62183.76218.59216.12
Operating Income
-38.77-170.73-59.92-183.76-218.59-216.12
Interest Income
2.031.971.7821.580.76
Interest Expense
-11-10.99-11.52-13.51-13.88-19.44
Other Non-Operating Income (Expense)
7.279.2914.0215.461.510.8
Total Non-Operating Income (Expense)
-1.70.274.283.94-10.79-17.88
Pretax Income
-38.27-170.46-55.64-179.82-229.38-234
Provision for Income Taxes
--0.090.89---
Net Income
-38.27-170.37-56.53-179.82-229.38-234
Net Income to Common
-38.27-170.37-56.53-179.82-229.38-234
Net Income Growth
------
Shares Outstanding (Basic)
2292292261538575
Shares Outstanding (Diluted)
2292292261538575
Shares Change (YoY)
-0.25%1.01%48.23%80.46%13.00%9.24%
EPS (Basic)
-0.79-0.75-0.25-1.18-2.71-3.13
EPS (Diluted)
-0.79-0.75-0.25-1.18-2.71-3.13
EPS Growth
------
Free Cash Flow
-170.32-171.35-3.47-159.16-187.44-190.44
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.74-0.75-0.02-1.04-2.22-2.54
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-69.80%-352.23%-52.24%---
Profit Margin
-68.91%-351.49%-49.28%---
FCF Margin
-306.67%-353.50%-3.02%---
EBITDA
-37.87-169.73-55.77-179.37-214.16-210.96
EBITDA Margin
-68.19%-350.16%-48.62%---
EBIT
-38.77-170.73-59.92-183.76-218.59-216.12
EBIT Margin
-69.80%-352.23%-52.24%---
Effective Tax Rate
-0.05%-1.61%0.00%0.00%0.00%
SEC Filings: 10-K · 10-Q